Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma
Abstract Background Lymphoma is a common hematologic malignancy with limited treatment options. The research objective was to ascertain plasma proteins that could be targeted for lymphoma treatment. Methods We conducted proteome-wide mendelian randomization (PW-MR) analyses on blood proteins from th...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer
2025-11-01
|
| Collection: | Discover Oncology |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1007/s12672-025-03931-z |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|